To investigate the role of glucose in regulating glucose transporters in pancreatic β-cells, we studied the hamster clonal β-cell line HIT-T15, which retains responsiveness to glucose. Northern blot analysis demonstrates that GLUT2 and GLUT1 mRNA are abundant in HIT cells. After a 24-h culture with various concentrations of glucose (0–22.2 mM [0–400 mg/dl]), the GLUT2 mRNA level in HIT cells increased by 40% at 22.2 mM (400 mg/dl) glucose compared with 11.1 mM (200 mg/dl) without a change in mRNA stability. It also decreased proportionally to the reduction of glucose concentration. Glucose deprivation resulted in a decrease of GLUT2 mRNA to an almost undetectable level, with a marked increase in the degradation rate of mRNA. In contrast, the GLUT1 mRNA was not affected by glucose. We show that glucose uptake is highest in HIT cells incubated at 2.8–5.5 mM (50–99 mg/dl) glucose for 24 h, and that levels in cells cultured at 0 mM (0 mg/dl) and 22.2 mM (400 mg/dl) glucose decrease to ∼ 20% of the maximum level. This decrease is consistent with the effects of glucose on glucose-stimulated insulin secretion in HIT cells. Our results indicate that glucose is involved in regulating GLUT2 mRNA and glucose uptake activity and that the glucose responsiveness of the insulin secretion correlates with the glucose-induced change in glucose uptake activity in HIT cells.
Skip Nav Destination
Article navigation
Original Articles|
May 01 1992
Glucose as Regulator of Glucose Transport Activity and Glucose-Transporter mRNA in Hamster β-Cell Line
Nobuya Inagaki;
Nobuya Inagaki
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Koichiro Yasuda;
Koichiro Yasuda
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Gen Inoue;
Gen Inoue
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Yoshimasa Okamoto;
Yoshimasa Okamoto
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Hideki Yano;
Hideki Yano
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Yoshimichi Someya;
Yoshimichi Someya
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Yasuka Ohmoto;
Yasuka Ohmoto
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Kyohei Deguchi;
Kyohei Deguchi
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Ken-Ichi Imagawa;
Ken-Ichi Imagawa
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Hiroo Imura;
Hiroo Imura
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Yutaka Seino
Yutaka Seino
Second Division, Departments of Medicine, Metabolism, and Clinical Nutrition, Kyoto University Faculty of Medicine
Kyoto
Cellular Technology Institute, and Department of Viral Diseases, Tokushima Research Institute, Otsuka Pharmaceutical Company. Limited
Tokushima, Japan
Search for other works by this author on:
Address correspondence and reprint requests to Nobuya Inagaki, MD, Second Division, Department of Medicine, Kyoto University School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606, Japan.
Diabetes 1992;41(5):592–597
Article history
Received:
May 23 1991
Revision Received:
January 02 1992
Accepted:
January 02 1992
PubMed:
1568528
Citation
Nobuya Inagaki, Koichiro Yasuda, Gen Inoue, Yoshimasa Okamoto, Hideki Yano, Yoshimichi Someya, Yasuka Ohmoto, Kyohei Deguchi, Ken-Ichi Imagawa, Hiroo Imura, Yutaka Seino; Glucose as Regulator of Glucose Transport Activity and Glucose-Transporter mRNA in Hamster β-Cell Line. Diabetes 1 May 1992; 41 (5): 592–597. https://doi.org/10.2337/diab.41.5.592
Download citation file:
57
Views